The market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.
Arbourinvestments
8xbet
Uuz
88bet
Mcconnell Hoyle
Hu88
Gp88
Mack
Ulriksen Urquhart
Piper Moran